S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.38%) $966.30
USD/EUR
(-0.36%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Realtime updates for First Trust Heitman [PRME]

Exchange: NYSE Sector: Healthcare Industry: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 14.47%

BUY
100.00%
return 6.79%
SELL
50.00%
return 3.93%
Last Updated3 May 2024 @ 16:00

-0.36% $ 5.59

BUY 114043 min ago

@ $6.86

Issued: 14 Feb 2024 @ 15:49


Return: -18.51%


Previous signal: Feb 14 - 09:30


Previous signal: Sell


Return: 2.01 %

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 16:00):

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence...

Stats
Today's Volume 909 022
Average Volume 755 012
Market Cap 670.96M
EPS $0 ( 2024-03-14 )
Next earnings date ( $-0.450 ) 2024-05-09
Last Dividend $0.800 ( 2019-09-10 )
Next Dividend $0 ( N/A )
P/E -2.56
ATR14 $0.0100 (0.18%)
Insider Trading
Date Person Action Amount type
2024-02-29 Marrazzo Jeffrey D Buy 250 000 Stock Option (right to buy)
2024-02-20 Gv 2023 Gp, L.l.c. Buy 0 Common Stock
2024-02-25 Gottesdiener Keith Michael Buy 100 000 Stock Option (right to buy)
2024-02-21 Brudnick Richard Buy 135 747 Stock Option (right to buy)
2024-02-21 Duffield Jeremy Buy 180 995 Stock Option (right to buy)
INSIDER POWER
35.09
Last 97 transactions
Buy: 38 299 882 | Sell: 27 394 093

Volume Correlation

Long: 0.26 (neutral)
Short: -0.49 (neutral)
Signal:(50.936) Neutral

First Trust Heitman Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

First Trust Heitman Correlation - Currency/Commodity

The country flag -0.20
( neutral )
The country flag -0.01
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.67
( moderate negative )
The country flag -0.22
( neutral )

First Trust Heitman Financials

Annual 2023
Revenue: $0
Gross Profit: $-4.65M (0.00 %)
EPS: $-2.18
FY 2023
Revenue: $0
Gross Profit: $-4.65M (0.00 %)
EPS: $-2.18
FY 2022
Revenue: $5.21M
Gross Profit: $-6.80M (-130.60 %)
EPS: $-1.250
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-2.55

Financial Reports:

No articles found.

First Trust Heitman Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

First Trust Heitman Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.0900 2015-12-23
Last Dividend $0.800 2019-09-10
Next Dividend $0 N/A
Payout Date 2019-09-12
Next Payout Date N/A
# dividends 15 --
Total Paid Out $3.83 --
Avg. Dividend % Per Year 0.00% --
Score 1.65 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-21)
$0 Estimate 0.00 %
Dividend Stability
0.09 Very Bad
Dividend Score
1.65
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
SCM Dividend King 2023-12-15 Monthly 13 7.08% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-1.0221.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.9371.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.530.8002.331.864[1 - 3]
quickRatioTTM2.160.8002.021.617[0.8 - 2.5]
cashRatioTTM0.7371.5007.0210.00[0.2 - 2]
debtRatioTTM0.0703-1.5008.83-10.00[0 - 0.6]
interestCoverageTTM440.771.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
freeCashFlowPerShareTTM-1.7882.00-0.894-1.788[0 - 20]
debtEquityRatioTTM0.102-1.5009.59-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-12.131.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.156

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.761.000-0.3800[1 - 100]
returnOnEquityTTM-0.9372.50-7.41-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.7882.00-0.596-1.788[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.07911.500-2.810[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.941

First Trust Heitman

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators